| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dce61e02726b8895a9a292d4fb052db |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86bb7ccb11632a461a2b375fdc5b11a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d94a6ee3300a7e5fcb6c43c9fb8d440
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2d908ca6eced5af91fcfe1d8d500c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2fe7c15219ae30008196d09c5f743ed |
| publicationDate |
2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020013308-A2 |
| titleOfInvention |
use of a compound of formula i, a deuterated analogue or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of hemorrhagic stroke in an individual |
| abstract |
a use of 5a-androstane-3ß, 5,6ß-triol, an analogue, a deuterated derivative and a pharmaceutically acceptable salt thereof is disclosed in the manufacture of a medicament for the treatment of hemorrhagic stroke in a patient. hemorrhagic stroke is intracerebral hemorrhage or subarachnoid hemorrhage. |
| priorityDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |